04.03.2015 • NewsDede WillamsAstraZenecaActavis

AstraZeneca Buy of Actavis’ Respiratory Products Complete

AstraZeneca has completed its acquisition of the rights to Actavis' branded respiratory business in the US and Canada.

The UK-Swedish drugmaker said the buy strengthens its respiratory franchise globally and builds on its acquisition of Almirall's respiratory portfolio in 2014, as it extends the company's development and commercialization rights into the US for both Tudorza Pressair (aclidinium bromide inhalation powder) and Duaklir Genuair (a dry powder inhaler).

Among other products, AstraZeneca owns the development and commercial rights in the US and Canada to Tudorza Pressair and Duaklir Genuair as well as the twice-daily long-acting muscarinic antagonist LAMA for chronic obstructive pulmonary disease (COPD) and Daliresp (roflumilast), the only once-daily oral PDE4 inhibitor currently on the market for COPD, in the US.

On completion of the acquisition, the drugmaker will pay Activis an initial consideration of $600 million and has agreed to pay low single-digit royalties above a certain revenue threshold.

AstraZeneca has also paid Actavis an additional $100 million for a number of contractual consents and approvals, including certain amendments to the ongoing collaboration agreements between the two companies.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.